Liver transplantation for chronic viral hepatitis

Surgical Clinics of North America

Volumn 79, Issue 1, 1999, Pages 131-145

  Dodson, S F ^a   Issa, S ^a   Bonham, A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; VIRUS ANTIBODY;

CHRONIC HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER TRANSPLANTATION; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REOPERATION; REVIEW; SCREENING TEST; SURVIVAL RATE; TREATMENT INDICATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0033028008     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70010-4     Document Type: Article

References (95)

1. M.A. Aldersley R.E. Eglin J.G. O'Grady Liver transplantation and de novo hepatitis B infection Lancet 343 1994 677
2. V. Araya F.S. Dodson Dvorchik Efficacy and safety of alpha interferon for hepatitis C after liver transplantation [abstract 673] Hepatology 24 1996 295A
3. J.C. Arnold U. Tox T. Goeser Recurrent hepatitis C virus infection after liver transplantation: Long-term follow-up with respect to the HCV genotype/subtypes Zeitschrift fur Gastroenterologie 35 4 1997 255 261
4. V.G. Bain N.M. Kneteman M.M. Ma Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation Transplantation 62 1996 1456 1462
5. M.M. Bartholomew R.W. Jansen L.J. Jeffers Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation Lancet 349 1997 20 22
6. L.S. Belli E. Silini A. Alberti Hepatitis C virus genotypes, hepatitis, and hepatitis C recurrence after liver transplantation Liver Transplant Surg 2 1996 200 205
7. K.G. Benner R.G. Lee E.B. Keeffe Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation Gastroenterology 103 1992 1307 1312
8. G. Bettale A. Alberti L.S. Belli Recurrence of HBV infection after liver transplantation Prog Clin Biol Res 382 1993 403 407
9. T. Bizollon U. Palazzo C. Ducerf Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation Hepatology 26 1997 500 504
10. J. Bloomer R. Chan P. Sherman A preliminary study of lobucavir for chronic hepatitis B [abstract 1199] Hepatology 3 1997 428A
11. K.H. Boker G. Dalley M.J. Bahr Long-term outcome of hepatitis C virus infection after liver transplantation Hepatology 25 1997 203 210
12. F.A. Casavilla R. Lee J. Lim Outcome of liver retransplantation (ReOLTx) for recurrent hepatitis C infection [abstract 188] Hepatology 22 1995 153A
13. O. Chazouilleres M. Kim C. Combs Quantitation of hepatitis C virus RNA in liver transplant recipients Gastroenterology 106 1994 994 999
14. O. Chazouilleres D. Mamish M. Kim “Occult” hepatitis B virus as source of infection in liver transplant recipients Lancet 343 1994 142 146
15. J.L. Corman C.W. Punam S. Iwatsuki Liver allograft: Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen Arch Surg 114 1979 75 78
16. A.J. Czaja S.J. Beaver J.R. Wood Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis Gastroenterology 93 1987 687 692
17. S.E. Davies B.C. Portmann J.G. O'Grady Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis Hepatology 13 1991 150 157
18. A.J. Demetris R. Jaffe D.G. Sheahan Recurrent hepatitis B in liver allograft recipients: Differentiation between viral hepatitis B and rejection Am J Pathol 125 1986 161 172
19. A.J. Demetris S. Todo Van Thiel D.H. Evolution of hepatitis B virus liver disease after hepatic replacement: Practical and theoretical considerations Am J Pathol 137 1990 667 676
20. A.M. DiBisceglie J.H. Hoofnagle Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B Cancer 64 1989 2117 2120
21. S.F. Dodson V. Araya V. Balan A pilot study of lamivudine for the treatment of hepatitis B infection after liver transplantation [abstract 21] Liver Transplant Surg 3 1997 C43
22. S.F. Dodson V. Araya V. Balan Trial of ribavirin and alpha-interferon for the treatment of hepatitis C infection after liver transplantation [abstract 141] Liver Transplant Surg 3 1997 C66
23. S.F. Dodson S. Issa V. Araya Infectivity of hepatic allografts with antibodies to hepatitis B virus Transplantation 64 1997 1582 1584
24. D.D. Douglas J. Rakela T.L. Wright The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient Liver Transplant Surg 3 1997 105 111
25. C. Duvoux J.M. Pawlotsky D. Cherqui Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation Transplantation 60 1995 457 461
26. C. Feray M. Gigou D. Samuel The course of hepatitis C virus infection after liver transplantation Hepatology 20 1994 1137 1143
27. C. Feray M. Gigou D. Samuel Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation Gastroenterology 108 1995 1088 1096
28. C. Feray A. Habsanne D. Samuel Poor prognosis of patients retransplanted for recurrent liver disease due to hepatitis C virus [abstract 113] Hepatology 22 1995 135A
29. C. Feray D. Samuel M. Gigou An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection Hepatology 22 1995 1084 1089
30. C. Feray D. Samuel V. Thiers Reinfection of liver graft by hepatitis C virus after liver transplantation J Clin Invest 89 1992 1361 1365
31. J.J. Fung B. Eghtesad S. Todo Hepatitis B virus (HBV) re-infection following liver transplantation: Theory and practice Clin Transplant 9 1995 262 268
32. J.J. Fung L. Ostberg R. Shapiro Human monoclonal antibody against hepatitis B surface antigen in preventing recurrent hepatitis B following liver transplantation Hollinger F. Lemon S. Margolis H. Viral Hepatitis and Liver Disease 1991 Williams & Wilkins Baltimore 651
33. E.J. Gane N.V. Naoumov K. Qian A longitudinal analysis of hepatitis C virus replication following liver transplantation Gastroenterology 110 1996 167 177
34. E.J. Gane B.C. Portmann N.V. Naoumov Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815 820
35. T. Gayowski N. Singh I.R. Marino Hepatitis C virus genotypes in liver transplant recipients: Impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome Transplantation 64 1997 422 426
36. R.M. Ghobrial S. Colquhoun H. Rosen Result analysis of retransplantation for hepatitis C [abstract 194] Hepatology 26 1997 177A
37. R.J.C. Gilson K. Chopra I. Murray-Lyon A placebo-controlled phase I/II study of adefovir dipivoxil (bis-pom pmea) in patients with chronic hepatitis B infection [abstract 620] Hepatology 24 1996 281A
38. R.G. Gish J.Y. Lau L. Brooks Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients Hepatology 23 1996 1 7
39. F.D. Gordon J.J. Poterucha J. Germer Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation Transplantation 63 1997 1419 1423
40. L.G. Grazi A. Mazziotti C. Sama Liver transplantation in HBsAg-positive HBV-DNA–negative cirrhotics: Immunoprophylaxis and long-term outcome Liver Transpl Surg 2 1996 418 425
41. L. Grellier D. Mutimer M. Ahmed Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis Lancet 348 1996 1212 1215
42. D.R. Gretch C.E. Bacchi L. Corey Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features Hepatology 22 1995 1 9
43. V.E. Grottola P. Butttafoco A.L. Merighi Long-term follow-up of hepatitis C virus (HCV) infection in liver transplant patients Clin Transplant 9 1995 160 164
44. J. Gugenheim E. Baldini D. Ouzan Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation Transplant Proc 29 1997 517 518
45. S.J. Hadziyannis M. Sherman H.M. Lieberman Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers Hepatology 5 1985 544 547
46. G.W. Haller W.O. Bechstein R. Neuhaus Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation Transplant Int 9 suppl 1 1996 210 212
47. K. Ikeda S. Saitoh I. Koida A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis Hepatology 18 1993 47 53
48. V. Konig U. Hopf P. Neuhaus Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation Transplantation 58 1994 553 559
49. K. Krogsgaard P. Kryger J. Aldershville Infection and suppression of hepatitis B virus replication in chronic HBsAg carriers Hepatology 7 1987 42 45
50. J.M. Langrehr H. Lemmens H. Keck Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis Transplant Proc 27 1995 1215 1216
51. T. Laskus L.F. Wang J. Rakela Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors Virology 220 1996 171 176
52. W. Lauchart R. Muller R. Pichlmayr Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts Transplant Proc 19 1987 2387 2389
53. W. Lauchart R. Muller R. Pichlmayr Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts Transplant Proc 19 1987 4051 4053
54. W.A. Marsman R.H. Wiesner K.P. Batts Fulminant hepatitis B virus: Recurrence after liver transplantation in two patients also infected with hepatitis delta virus Hepatology 25 1997 434 438
55. A. Marzano A. Ottobrelli D. Ezio Hepatitis delta virus infection and disease: The lesson from the liver transplantation model Prog Clin Biol Res 364 1991 429 436
56. A. Marzano A. Smedile M. Abate Hepatitis type C after orthotopic liver transplantation: Reinfection and disease recurrence J Hepatol 21 1994 961 965
57. R. Mateo A.J. Demetris E. Sico Early detection of de novo hepatitis C infection in patients after liver transplantation by reverse transcriptase polymerase chain reaction Surgery 114 1993 442 448
58. D.S. Matheson T.W. Clarkson E.W. Gelfand Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin J Pediatr 97 1980 153
59. V. Mazzaferro E. Regalia A. Pulvirenti Prophylaxis against HCV recurrence after liver transplantation with interferon and ribavirin combination [abstract 14] Liver Transplant Surg 3 1997 C41
60. R.W. McGory M.B. Ishitoni W.M. Oliveira Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization Transplantation 61 1996 1358 1364
61. G. McMahon P.H. Ehrlich Z.A. Moustafa Genetic alterations in the gene encoding the major HBsAg: DNA and immunologic analysis of recurrent HBsAg derived from monoclonal antibody-treated recipients Hepatology 15 1992 757
62. N.P. Mora G.B. Klintmalm S.S. Poplawski Recurrence of hepatitis B after liver transplantation: Does hepatitis B immunoglobulin modify the recurrent disease? Transplant Proc 22 1990 1549 1550
63. R. Muller G. Gubernatis M. Farle Liver transplantation in HBs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunization J Hepatol 13 1991 90 96
64. D.C. Mulligan R.M. Goldstein J.S. Crippin Use of anti-hepatitis C virus seropositive organs in liver transplantation Transplant Proc 27 1995 1204 1205
65. T. Nymann M.H. Shokouh-Amiri S.R. Vera Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation Clin Transplant 10 1996 663 667
66. J.H. Oliver R.L. Baron M.P. Federle Detecting hepatocellular carcinoma: The relative added value of using noncontrast and/or arterial phase imaging in conjunction with conventional portal venous phase contrast CT AJR Am J Roentgenol 167 1996 71 77
67. R. Perrillo J. Rakela P. Martin Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation (OLT) [abstract 526] Hepatology 26 1997 152A
68. R. Perrillo J. Rakela P. Martin Long-term lamivudine therapy of patients with recurrent hepatitis B post liver transplantation [abstract 196] Hepatology 26 1997 177A
69. G. Philippe J. Ducos A. Mondain Hepatitis C virus genotypes of serum hepatitis C virus R transplant recipients: Relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection Liver Transplant Surg 3 1997 501 505
70. J.J. Poterucha J. Rakela L. Lumeng Diagnosis of hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction Hepatology 15 1992 42 45
71. M. Rizzetto M.G. Canese J.L. Gerin Transmission of the hepatitis B virus associated delta antigen to chimpanzees J Infect Dis 141 1980 590 602
72. B. Roche D. Samuel M. Gigou De novo and apparent de novo hepatitis B virus infection after liver transplantation J Hepatol 26 1997 517 526
73. H.R. Rosen C.R. Shackleton L. Higa Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation Am J Gastroenterol 92 1997 1453 1457
74. R. Sallie A.T. Cohen C.J. Tibbs Recurrence of hepatitis C following orthotopic liver transplantation: A polymerase chain reaction and histological study J Hepatol 21 1994 536 542
75. D. Samuel A. Bismuth D. Mathieau Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients Lancet 337 1991 813 815
76. D. Samuel R. Muller G. Alexander Liver transplantation in European patients with the hepatitis B surface antigen N Engl J Med 329 1993 1842 1847
77. D. Samuel A. Zignego M. Reynes Long-term and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis Hepatology 21 1995 333 339
78. P.A. Sheiner E. Mor M.E. Schwartz Use of hepatitis C-positive donors in liver transplantation Transplant Proc 25 1993 3071
79. P.A. Sheiner L.K. Schluger S. Emre Retransplantation for recurrent hepatitis C Liver Transplant Surg 3 1997 130 136
80. P.A. Sheiner M.E. Schwartz E. Mor Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation Hepatology 21 1995 30 34
81. M.L. Shiffman M.J. Contos V.A. Luketic Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation Transplantation 57 1994 526 532
82. N. Singh T. Gayowski Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation Transplantation 59 1995 1629 1630
83. N. Singh T. Gayowski O.K. Ndimbie Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: Association with rejection and increased immunosuppression after transplantation Surgery 119 1996 452 456
84. N.A. Terrault C.C. Holland L. Ferrell Interferon alfa for recurrent hepatitis B infection after liver transplantation 2 1996 132 138
85. N.A. Terrault S. Zhou C. Combs Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin Hepatology 24 1996 1327 1333
86. S. Todo A.J. Demetris Van Thiel D. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease Hepatology 13 1991 619 626
87. M. Torisu T. Yokoyama H. Amemiya Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: With particular reference to the Australia antigen Ann Surg 174 1971 620 639
88. Van Thiel D.H. el-Ashmawy L. K. Love Response to hepatitis B vaccination by liver transplant candidates Dig Dis Sci 37 1992 1245 1249
89. H.E. Vargas T. Laskus L. Wang The influence of hepatitis C virus genotypes on the outcome of liver transplantation 4 1998 22 27
90. H.E. Vargas T. Laskus L. Wang Outcome of liver transplantation of HCV positive grafts in HCV infected recipients [abstract 103] Hepatology 26 1997 154A
91. M.E. Wachs W.J. Amend N.L. Ascher The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors Transplantation 59 1995 230 234
92. T.L. Wright C. Combs M. Kim Interferon-alpha therapy for hepatitis C virus infection after liver transplantation Hepatology 20 1994 773 779
93. T.L. Wright E. Donegan H. Hsu Recurrent and acquired hepatitis C viral infection in liver transplant recipients Gastroenterology 103 1992 317 322
94. J.C. Wu P.J. Chen M.Y.P. Kuo Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line J Virol 65 1991 1099 1104
95. S. Zhou N.A. Terrault L. Ferrell Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: Relationship to genotype and level of viremia Hepatology 24 1996 1041 1046